Cargando…
Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
The picture of chronic liver diseases (CLDs) has changed considerably in recent years. One of them is the increase of non-alcoholic fatty liver disease. More and more CLD patients, even those with liver cirrhosis (LC), tend to be presenting with obesity these days. The annual rate of muscle loss inc...
Autores principales: | Nishikawa, Hiroki, Enomoto, Hirayuki, Nishiguchi, Shuhei, Iijima, Hiroko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919019/ https://www.ncbi.nlm.nih.gov/pubmed/33671926 http://dx.doi.org/10.3390/ijms22041917 |
Ejemplares similares
-
Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020) -
Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2021) -
Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies
por: Enomoto, Hirayuki, et al.
Publicado: (2020) -
Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study
por: Nishikawa, Hiroki, et al.
Publicado: (2021) -
Frailty and Sleep Disorder in Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)